Growth Metrics

Idexx Laboratories (IDXX) Change in Receivables (2016 - 2026)

Idexx Laboratories has reported Change in Receivables over the past 17 years, most recently at -$13.9 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 50.14% year-over-year to -$13.9 million; the TTM value through Dec 2025 reached $68.7 million, up 143.01%, while the annual FY2025 figure was $68.7 million, 143.01% up from the prior year.
  • Change in Receivables for Q4 2025 was -$13.9 million at Idexx Laboratories, down from $7.7 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $54.7 million in Q1 2021 and troughed at -$27.8 million in Q4 2024.
  • A 5-year average of $11.3 million and a median of $7.0 million in 2022 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: soared 505.16% in 2022 and later plummeted 3953.5% in 2024.
  • Year by year, Change in Receivables stood at -$15.9 million in 2021, then skyrocketed by 139.83% to $6.3 million in 2022, then crashed by 110.83% to -$686000.0 in 2023, then plummeted by 3953.5% to -$27.8 million in 2024, then skyrocketed by 50.14% to -$13.9 million in 2025.
  • Business Quant data shows Change in Receivables for IDXX at -$13.9 million in Q4 2025, $7.7 million in Q3 2025, and $29.6 million in Q2 2025.